Global Breast Cancer Liquid Biopsy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Breast Cancer Liquid Biopsy market size was valued at US$ 1562.8 million in 2023. With growing demand in downstream market, the Breast Cancer Liquid Biopsy is forecast to a readjusted size of US$ 2226.5 million by 2030 with a CAGR of 5.2% during review period.
The research report highlights the growth potential of the global Breast Cancer Liquid Biopsy market. Breast Cancer Liquid Biopsy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Breast Cancer Liquid Biopsy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Breast Cancer Liquid Biopsy market.
Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.
Key Features:
The report on Breast Cancer Liquid Biopsy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Breast Cancer Liquid Biopsy market. It may include historical data, market segmentation by Type (e.g., Circulating Tumor Cells (CTCs), Cell-Free DNA (CfDNA)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Breast Cancer Liquid Biopsy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Breast Cancer Liquid Biopsy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Breast Cancer Liquid Biopsy industry. This include advancements in Breast Cancer Liquid Biopsy technology, Breast Cancer Liquid Biopsy new entrants, Breast Cancer Liquid Biopsy new investment, and other innovations that are shaping the future of Breast Cancer Liquid Biopsy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Breast Cancer Liquid Biopsy market. It includes factors influencing customer ' purchasing decisions, preferences for Breast Cancer Liquid Biopsy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Breast Cancer Liquid Biopsy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Breast Cancer Liquid Biopsy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Breast Cancer Liquid Biopsy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Breast Cancer Liquid Biopsy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Breast Cancer Liquid Biopsy market.
Market Segmentation:
Breast Cancer Liquid Biopsy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
According to our LPI (LP Information) latest study, the global Breast Cancer Liquid Biopsy market size was valued at US$ 1562.8 million in 2023. With growing demand in downstream market, the Breast Cancer Liquid Biopsy is forecast to a readjusted size of US$ 2226.5 million by 2030 with a CAGR of 5.2% during review period.
The research report highlights the growth potential of the global Breast Cancer Liquid Biopsy market. Breast Cancer Liquid Biopsy are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Breast Cancer Liquid Biopsy. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Breast Cancer Liquid Biopsy market.
Breast Cancer Liquid Biopsy can be usually used in breast biopsy, based on circulating biomarkers, the market is categorized into circulating tumor cells (CTCs), cell-free DNA (cfDNA), extracellular vesicles (EVs), and other circulating biomarkers.
Key Features:
The report on Breast Cancer Liquid Biopsy market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Breast Cancer Liquid Biopsy market. It may include historical data, market segmentation by Type (e.g., Circulating Tumor Cells (CTCs), Cell-Free DNA (CfDNA)), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Breast Cancer Liquid Biopsy market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Breast Cancer Liquid Biopsy market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Breast Cancer Liquid Biopsy industry. This include advancements in Breast Cancer Liquid Biopsy technology, Breast Cancer Liquid Biopsy new entrants, Breast Cancer Liquid Biopsy new investment, and other innovations that are shaping the future of Breast Cancer Liquid Biopsy.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Breast Cancer Liquid Biopsy market. It includes factors influencing customer ' purchasing decisions, preferences for Breast Cancer Liquid Biopsy product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Breast Cancer Liquid Biopsy market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Breast Cancer Liquid Biopsy market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Breast Cancer Liquid Biopsy market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Breast Cancer Liquid Biopsy industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Breast Cancer Liquid Biopsy market.
Market Segmentation:
Breast Cancer Liquid Biopsy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
- Circulating Tumor Cells (CTCs)
- Cell-Free DNA (CfDNA)
- Extracellular Vesicles (EVs)
- Other Circulating Biomarkers
- Hospitals
- Diagnostic Centers
- Laboratories
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- QIAGEN
- Roche Diagnostics
- Bio-Rad Laboratories
- Myriad Genetics
- Menarini Silicon Biosystems
- Genomic Health
- Thermo Fisher Scientific
- Illumina
- Biocept
- Trovagene
- Guardant Health
- RainDance Technologies
- MDx Health
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Breast Cancer Liquid Biopsy Market Size 2019-2030
2.1.2 Breast Cancer Liquid Biopsy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Breast Cancer Liquid Biopsy Segment by Type
2.2.1 Circulating Tumor Cells (CTCs)
2.2.2 Cell-Free DNA (CfDNA)
2.2.3 Extracellular Vesicles (EVs)
2.2.4 Other Circulating Biomarkers
2.3 Breast Cancer Liquid Biopsy Market Size by Type
2.3.1 Breast Cancer Liquid Biopsy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
2.4 Breast Cancer Liquid Biopsy Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostic Centers
2.4.3 Laboratories
2.5 Breast Cancer Liquid Biopsy Market Size by Application
2.5.1 Breast Cancer Liquid Biopsy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Breast Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
3 BREAST CANCER LIQUID BIOPSY MARKET SIZE BY PLAYER
3.1 Breast Cancer Liquid Biopsy Market Size Market Share by Players
3.1.1 Global Breast Cancer Liquid Biopsy Revenue by Players (2019-2024)
3.1.2 Global Breast Cancer Liquid Biopsy Revenue Market Share by Players (2019-2024)
3.2 Global Breast Cancer Liquid Biopsy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BREAST CANCER LIQUID BIOPSY BY REGIONS
4.1 Breast Cancer Liquid Biopsy Market Size by Regions (2019-2024)
4.2 Americas Breast Cancer Liquid Biopsy Market Size Growth (2019-2024)
4.3 APAC Breast Cancer Liquid Biopsy Market Size Growth (2019-2024)
4.4 Europe Breast Cancer Liquid Biopsy Market Size Growth (2019-2024)
4.5 Middle East & Africa Breast Cancer Liquid Biopsy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Breast Cancer Liquid Biopsy Market Size by Country (2019-2024)
5.2 Americas Breast Cancer Liquid Biopsy Market Size by Type (2019-2024)
5.3 Americas Breast Cancer Liquid Biopsy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Breast Cancer Liquid Biopsy Market Size by Region (2019-2024)
6.2 APAC Breast Cancer Liquid Biopsy Market Size by Type (2019-2024)
6.3 APAC Breast Cancer Liquid Biopsy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Breast Cancer Liquid Biopsy by Country (2019-2024)
7.2 Europe Breast Cancer Liquid Biopsy Market Size by Type (2019-2024)
7.3 Europe Breast Cancer Liquid Biopsy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Breast Cancer Liquid Biopsy by Region (2019-2024)
8.2 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type (2019-2024)
8.3 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BREAST CANCER LIQUID BIOPSY MARKET FORECAST
10.1 Global Breast Cancer Liquid Biopsy Forecast by Regions (2025-2030)
10.1.1 Global Breast Cancer Liquid Biopsy Forecast by Regions (2025-2030)
10.1.2 Americas Breast Cancer Liquid Biopsy Forecast
10.1.3 APAC Breast Cancer Liquid Biopsy Forecast
10.1.4 Europe Breast Cancer Liquid Biopsy Forecast
10.1.5 Middle East & Africa Breast Cancer Liquid Biopsy Forecast
10.2 Americas Breast Cancer Liquid Biopsy Forecast by Country (2025-2030)
10.2.1 United States Breast Cancer Liquid Biopsy Market Forecast
10.2.2 Canada Breast Cancer Liquid Biopsy Market Forecast
10.2.3 Mexico Breast Cancer Liquid Biopsy Market Forecast
10.2.4 Brazil Breast Cancer Liquid Biopsy Market Forecast
10.3 APAC Breast Cancer Liquid Biopsy Forecast by Region (2025-2030)
10.3.1 China Breast Cancer Liquid Biopsy Market Forecast
10.3.2 Japan Breast Cancer Liquid Biopsy Market Forecast
10.3.3 Korea Breast Cancer Liquid Biopsy Market Forecast
10.3.4 Southeast Asia Breast Cancer Liquid Biopsy Market Forecast
10.3.5 India Breast Cancer Liquid Biopsy Market Forecast
10.3.6 Australia Breast Cancer Liquid Biopsy Market Forecast
10.4 Europe Breast Cancer Liquid Biopsy Forecast by Country (2025-2030)
10.4.1 Germany Breast Cancer Liquid Biopsy Market Forecast
10.4.2 France Breast Cancer Liquid Biopsy Market Forecast
10.4.3 UK Breast Cancer Liquid Biopsy Market Forecast
10.4.4 Italy Breast Cancer Liquid Biopsy Market Forecast
10.4.5 Russia Breast Cancer Liquid Biopsy Market Forecast
10.5 Middle East & Africa Breast Cancer Liquid Biopsy Forecast by Region (2025-2030)
10.5.1 Egypt Breast Cancer Liquid Biopsy Market Forecast
10.5.2 South Africa Breast Cancer Liquid Biopsy Market Forecast
10.5.3 Israel Breast Cancer Liquid Biopsy Market Forecast
10.5.4 Turkey Breast Cancer Liquid Biopsy Market Forecast
10.5.5 GCC Countries Breast Cancer Liquid Biopsy Market Forecast
10.6 Global Breast Cancer Liquid Biopsy Forecast by Type (2025-2030)
10.7 Global Breast Cancer Liquid Biopsy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 QIAGEN
11.1.1 QIAGEN Company Information
11.1.2 QIAGEN Breast Cancer Liquid Biopsy Product Offered
11.1.3 QIAGEN Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 QIAGEN Main Business Overview
11.1.5 QIAGEN Latest Developments
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Information
11.2.2 Roche Diagnostics Breast Cancer Liquid Biopsy Product Offered
11.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Diagnostics Main Business Overview
11.2.5 Roche Diagnostics Latest Developments
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Information
11.3.2 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product Offered
11.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bio-Rad Laboratories Main Business Overview
11.3.5 Bio-Rad Laboratories Latest Developments
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Information
11.4.2 Myriad Genetics Breast Cancer Liquid Biopsy Product Offered
11.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Myriad Genetics Main Business Overview
11.4.5 Myriad Genetics Latest Developments
11.5 Menarini Silicon Biosystems
11.5.1 Menarini Silicon Biosystems Company Information
11.5.2 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product Offered
11.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Menarini Silicon Biosystems Main Business Overview
11.5.5 Menarini Silicon Biosystems Latest Developments
11.6 Genomic Health
11.6.1 Genomic Health Company Information
11.6.2 Genomic Health Breast Cancer Liquid Biopsy Product Offered
11.6.3 Genomic Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Genomic Health Main Business Overview
11.6.5 Genomic Health Latest Developments
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Information
11.7.2 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product Offered
11.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Thermo Fisher Scientific Main Business Overview
11.7.5 Thermo Fisher Scientific Latest Developments
11.8 Illumina
11.8.1 Illumina Company Information
11.8.2 Illumina Breast Cancer Liquid Biopsy Product Offered
11.8.3 Illumina Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Illumina Main Business Overview
11.8.5 Illumina Latest Developments
11.9 Biocept
11.9.1 Biocept Company Information
11.9.2 Biocept Breast Cancer Liquid Biopsy Product Offered
11.9.3 Biocept Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Biocept Main Business Overview
11.9.5 Biocept Latest Developments
11.10 Trovagene
11.10.1 Trovagene Company Information
11.10.2 Trovagene Breast Cancer Liquid Biopsy Product Offered
11.10.3 Trovagene Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Trovagene Main Business Overview
11.10.5 Trovagene Latest Developments
11.11 Guardant Health
11.11.1 Guardant Health Company Information
11.11.2 Guardant Health Breast Cancer Liquid Biopsy Product Offered
11.11.3 Guardant Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Guardant Health Main Business Overview
11.11.5 Guardant Health Latest Developments
11.12 RainDance Technologies
11.12.1 RainDance Technologies Company Information
11.12.2 RainDance Technologies Breast Cancer Liquid Biopsy Product Offered
11.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 RainDance Technologies Main Business Overview
11.12.5 RainDance Technologies Latest Developments
11.13 MDx Health
11.13.1 MDx Health Company Information
11.13.2 MDx Health Breast Cancer Liquid Biopsy Product Offered
11.13.3 MDx Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 MDx Health Main Business Overview
11.13.5 MDx Health Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Breast Cancer Liquid Biopsy Market Size 2019-2030
2.1.2 Breast Cancer Liquid Biopsy Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Breast Cancer Liquid Biopsy Segment by Type
2.2.1 Circulating Tumor Cells (CTCs)
2.2.2 Cell-Free DNA (CfDNA)
2.2.3 Extracellular Vesicles (EVs)
2.2.4 Other Circulating Biomarkers
2.3 Breast Cancer Liquid Biopsy Market Size by Type
2.3.1 Breast Cancer Liquid Biopsy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
2.4 Breast Cancer Liquid Biopsy Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostic Centers
2.4.3 Laboratories
2.5 Breast Cancer Liquid Biopsy Market Size by Application
2.5.1 Breast Cancer Liquid Biopsy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Breast Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
3 BREAST CANCER LIQUID BIOPSY MARKET SIZE BY PLAYER
3.1 Breast Cancer Liquid Biopsy Market Size Market Share by Players
3.1.1 Global Breast Cancer Liquid Biopsy Revenue by Players (2019-2024)
3.1.2 Global Breast Cancer Liquid Biopsy Revenue Market Share by Players (2019-2024)
3.2 Global Breast Cancer Liquid Biopsy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 BREAST CANCER LIQUID BIOPSY BY REGIONS
4.1 Breast Cancer Liquid Biopsy Market Size by Regions (2019-2024)
4.2 Americas Breast Cancer Liquid Biopsy Market Size Growth (2019-2024)
4.3 APAC Breast Cancer Liquid Biopsy Market Size Growth (2019-2024)
4.4 Europe Breast Cancer Liquid Biopsy Market Size Growth (2019-2024)
4.5 Middle East & Africa Breast Cancer Liquid Biopsy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Breast Cancer Liquid Biopsy Market Size by Country (2019-2024)
5.2 Americas Breast Cancer Liquid Biopsy Market Size by Type (2019-2024)
5.3 Americas Breast Cancer Liquid Biopsy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Breast Cancer Liquid Biopsy Market Size by Region (2019-2024)
6.2 APAC Breast Cancer Liquid Biopsy Market Size by Type (2019-2024)
6.3 APAC Breast Cancer Liquid Biopsy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Breast Cancer Liquid Biopsy by Country (2019-2024)
7.2 Europe Breast Cancer Liquid Biopsy Market Size by Type (2019-2024)
7.3 Europe Breast Cancer Liquid Biopsy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Breast Cancer Liquid Biopsy by Region (2019-2024)
8.2 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type (2019-2024)
8.3 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL BREAST CANCER LIQUID BIOPSY MARKET FORECAST
10.1 Global Breast Cancer Liquid Biopsy Forecast by Regions (2025-2030)
10.1.1 Global Breast Cancer Liquid Biopsy Forecast by Regions (2025-2030)
10.1.2 Americas Breast Cancer Liquid Biopsy Forecast
10.1.3 APAC Breast Cancer Liquid Biopsy Forecast
10.1.4 Europe Breast Cancer Liquid Biopsy Forecast
10.1.5 Middle East & Africa Breast Cancer Liquid Biopsy Forecast
10.2 Americas Breast Cancer Liquid Biopsy Forecast by Country (2025-2030)
10.2.1 United States Breast Cancer Liquid Biopsy Market Forecast
10.2.2 Canada Breast Cancer Liquid Biopsy Market Forecast
10.2.3 Mexico Breast Cancer Liquid Biopsy Market Forecast
10.2.4 Brazil Breast Cancer Liquid Biopsy Market Forecast
10.3 APAC Breast Cancer Liquid Biopsy Forecast by Region (2025-2030)
10.3.1 China Breast Cancer Liquid Biopsy Market Forecast
10.3.2 Japan Breast Cancer Liquid Biopsy Market Forecast
10.3.3 Korea Breast Cancer Liquid Biopsy Market Forecast
10.3.4 Southeast Asia Breast Cancer Liquid Biopsy Market Forecast
10.3.5 India Breast Cancer Liquid Biopsy Market Forecast
10.3.6 Australia Breast Cancer Liquid Biopsy Market Forecast
10.4 Europe Breast Cancer Liquid Biopsy Forecast by Country (2025-2030)
10.4.1 Germany Breast Cancer Liquid Biopsy Market Forecast
10.4.2 France Breast Cancer Liquid Biopsy Market Forecast
10.4.3 UK Breast Cancer Liquid Biopsy Market Forecast
10.4.4 Italy Breast Cancer Liquid Biopsy Market Forecast
10.4.5 Russia Breast Cancer Liquid Biopsy Market Forecast
10.5 Middle East & Africa Breast Cancer Liquid Biopsy Forecast by Region (2025-2030)
10.5.1 Egypt Breast Cancer Liquid Biopsy Market Forecast
10.5.2 South Africa Breast Cancer Liquid Biopsy Market Forecast
10.5.3 Israel Breast Cancer Liquid Biopsy Market Forecast
10.5.4 Turkey Breast Cancer Liquid Biopsy Market Forecast
10.5.5 GCC Countries Breast Cancer Liquid Biopsy Market Forecast
10.6 Global Breast Cancer Liquid Biopsy Forecast by Type (2025-2030)
10.7 Global Breast Cancer Liquid Biopsy Forecast by Application (2025-2030)
11 KEY PLAYERS ANALYSIS
11.1 QIAGEN
11.1.1 QIAGEN Company Information
11.1.2 QIAGEN Breast Cancer Liquid Biopsy Product Offered
11.1.3 QIAGEN Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 QIAGEN Main Business Overview
11.1.5 QIAGEN Latest Developments
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Information
11.2.2 Roche Diagnostics Breast Cancer Liquid Biopsy Product Offered
11.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Roche Diagnostics Main Business Overview
11.2.5 Roche Diagnostics Latest Developments
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Information
11.3.2 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product Offered
11.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Bio-Rad Laboratories Main Business Overview
11.3.5 Bio-Rad Laboratories Latest Developments
11.4 Myriad Genetics
11.4.1 Myriad Genetics Company Information
11.4.2 Myriad Genetics Breast Cancer Liquid Biopsy Product Offered
11.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Myriad Genetics Main Business Overview
11.4.5 Myriad Genetics Latest Developments
11.5 Menarini Silicon Biosystems
11.5.1 Menarini Silicon Biosystems Company Information
11.5.2 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product Offered
11.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Menarini Silicon Biosystems Main Business Overview
11.5.5 Menarini Silicon Biosystems Latest Developments
11.6 Genomic Health
11.6.1 Genomic Health Company Information
11.6.2 Genomic Health Breast Cancer Liquid Biopsy Product Offered
11.6.3 Genomic Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Genomic Health Main Business Overview
11.6.5 Genomic Health Latest Developments
11.7 Thermo Fisher Scientific
11.7.1 Thermo Fisher Scientific Company Information
11.7.2 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product Offered
11.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Thermo Fisher Scientific Main Business Overview
11.7.5 Thermo Fisher Scientific Latest Developments
11.8 Illumina
11.8.1 Illumina Company Information
11.8.2 Illumina Breast Cancer Liquid Biopsy Product Offered
11.8.3 Illumina Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Illumina Main Business Overview
11.8.5 Illumina Latest Developments
11.9 Biocept
11.9.1 Biocept Company Information
11.9.2 Biocept Breast Cancer Liquid Biopsy Product Offered
11.9.3 Biocept Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Biocept Main Business Overview
11.9.5 Biocept Latest Developments
11.10 Trovagene
11.10.1 Trovagene Company Information
11.10.2 Trovagene Breast Cancer Liquid Biopsy Product Offered
11.10.3 Trovagene Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Trovagene Main Business Overview
11.10.5 Trovagene Latest Developments
11.11 Guardant Health
11.11.1 Guardant Health Company Information
11.11.2 Guardant Health Breast Cancer Liquid Biopsy Product Offered
11.11.3 Guardant Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Guardant Health Main Business Overview
11.11.5 Guardant Health Latest Developments
11.12 RainDance Technologies
11.12.1 RainDance Technologies Company Information
11.12.2 RainDance Technologies Breast Cancer Liquid Biopsy Product Offered
11.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 RainDance Technologies Main Business Overview
11.12.5 RainDance Technologies Latest Developments
11.13 MDx Health
11.13.1 MDx Health Company Information
11.13.2 MDx Health Breast Cancer Liquid Biopsy Product Offered
11.13.3 MDx Health Breast Cancer Liquid Biopsy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 MDx Health Main Business Overview
11.13.5 MDx Health Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Breast Cancer Liquid Biopsy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Circulating Tumor Cells (CTCs)
Table 3. Major Players of Cell-Free DNA (CfDNA)
Table 4. Major Players of Extracellular Vesicles (EVs)
Table 5. Major Players of Other Circulating Biomarkers
Table 6. Breast Cancer Liquid Biopsy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Breast Cancer Liquid Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
Table 9. Breast Cancer Liquid Biopsy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Breast Cancer Liquid Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Breast Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
Table 12. Global Breast Cancer Liquid Biopsy Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Breast Cancer Liquid Biopsy Revenue Market Share by Player (2019-2024)
Table 14. Breast Cancer Liquid Biopsy Key Players Head office and Products Offered
Table 15. Breast Cancer Liquid Biopsy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Breast Cancer Liquid Biopsy Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Breast Cancer Liquid Biopsy Market Size Market Share by Regions (2019-2024)
Table 20. Global Breast Cancer Liquid Biopsy Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Breast Cancer Liquid Biopsy Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Breast Cancer Liquid Biopsy Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Breast Cancer Liquid Biopsy Market Size Market Share by Country (2019-2024)
Table 24. Americas Breast Cancer Liquid Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
Table 26. Americas Breast Cancer Liquid Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Breast Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
Table 28. APAC Breast Cancer Liquid Biopsy Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Breast Cancer Liquid Biopsy Market Size Market Share by Region (2019-2024)
Table 30. APAC Breast Cancer Liquid Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
Table 32. APAC Breast Cancer Liquid Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Breast Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
Table 34. Europe Breast Cancer Liquid Biopsy Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Breast Cancer Liquid Biopsy Market Size Market Share by Country (2019-2024)
Table 36. Europe Breast Cancer Liquid Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
Table 38. Europe Breast Cancer Liquid Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Breast Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Breast Cancer Liquid Biopsy Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Breast Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Breast Cancer Liquid Biopsy
Table 47. Key Market Challenges & Risks of Breast Cancer Liquid Biopsy
Table 48. Key Industry Trends of Breast Cancer Liquid Biopsy
Table 49. Global Breast Cancer Liquid Biopsy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Breast Cancer Liquid Biopsy Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Breast Cancer Liquid Biopsy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Breast Cancer Liquid Biopsy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. QIAGEN Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 54. QIAGEN Breast Cancer Liquid Biopsy Product Offered
Table 55. QIAGEN Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. QIAGEN Main Business
Table 57. QIAGEN Latest Developments
Table 58. Roche Diagnostics Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 59. Roche Diagnostics Breast Cancer Liquid Biopsy Product Offered
Table 60. Roche Diagnostics Main Business
Table 61. Roche Diagnostics Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Roche Diagnostics Latest Developments
Table 63. Bio-Rad Laboratories Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 64. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product Offered
Table 65. Bio-Rad Laboratories Main Business
Table 66. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Bio-Rad Laboratories Latest Developments
Table 68. Myriad Genetics Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 69. Myriad Genetics Breast Cancer Liquid Biopsy Product Offered
Table 70. Myriad Genetics Main Business
Table 71. Myriad Genetics Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Myriad Genetics Latest Developments
Table 73. Menarini Silicon Biosystems Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 74. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product Offered
Table 75. Menarini Silicon Biosystems Main Business
Table 76. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Menarini Silicon Biosystems Latest Developments
Table 78. Genomic Health Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 79. Genomic Health Breast Cancer Liquid Biopsy Product Offered
Table 80. Genomic Health Main Business
Table 81. Genomic Health Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Genomic Health Latest Developments
Table 83. Thermo Fisher Scientific Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 84. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product Offered
Table 85. Thermo Fisher Scientific Main Business
Table 86. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Thermo Fisher Scientific Latest Developments
Table 88. Illumina Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 89. Illumina Breast Cancer Liquid Biopsy Product Offered
Table 90. Illumina Main Business
Table 91. Illumina Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Illumina Latest Developments
Table 93. Biocept Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 94. Biocept Breast Cancer Liquid Biopsy Product Offered
Table 95. Biocept Main Business
Table 96. Biocept Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Biocept Latest Developments
Table 98. Trovagene Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 99. Trovagene Breast Cancer Liquid Biopsy Product Offered
Table 100. Trovagene Main Business
Table 101. Trovagene Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Trovagene Latest Developments
Table 103. Guardant Health Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 104. Guardant Health Breast Cancer Liquid Biopsy Product Offered
Table 105. Guardant Health Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Guardant Health Main Business
Table 107. Guardant Health Latest Developments
Table 108. RainDance Technologies Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 109. RainDance Technologies Breast Cancer Liquid Biopsy Product Offered
Table 110. RainDance Technologies Main Business
Table 111. RainDance Technologies Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. RainDance Technologies Latest Developments
Table 113. MDx Health Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 114. MDx Health Breast Cancer Liquid Biopsy Product Offered
Table 115. MDx Health Main Business
Table 116. MDx Health Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. MDx Health Latest Developments
Table 1. Breast Cancer Liquid Biopsy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Circulating Tumor Cells (CTCs)
Table 3. Major Players of Cell-Free DNA (CfDNA)
Table 4. Major Players of Extracellular Vesicles (EVs)
Table 5. Major Players of Other Circulating Biomarkers
Table 6. Breast Cancer Liquid Biopsy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Breast Cancer Liquid Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
Table 9. Breast Cancer Liquid Biopsy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Breast Cancer Liquid Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Breast Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
Table 12. Global Breast Cancer Liquid Biopsy Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Breast Cancer Liquid Biopsy Revenue Market Share by Player (2019-2024)
Table 14. Breast Cancer Liquid Biopsy Key Players Head office and Products Offered
Table 15. Breast Cancer Liquid Biopsy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Breast Cancer Liquid Biopsy Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Breast Cancer Liquid Biopsy Market Size Market Share by Regions (2019-2024)
Table 20. Global Breast Cancer Liquid Biopsy Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Breast Cancer Liquid Biopsy Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Breast Cancer Liquid Biopsy Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Breast Cancer Liquid Biopsy Market Size Market Share by Country (2019-2024)
Table 24. Americas Breast Cancer Liquid Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
Table 26. Americas Breast Cancer Liquid Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Breast Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
Table 28. APAC Breast Cancer Liquid Biopsy Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Breast Cancer Liquid Biopsy Market Size Market Share by Region (2019-2024)
Table 30. APAC Breast Cancer Liquid Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
Table 32. APAC Breast Cancer Liquid Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Breast Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
Table 34. Europe Breast Cancer Liquid Biopsy Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Breast Cancer Liquid Biopsy Market Size Market Share by Country (2019-2024)
Table 36. Europe Breast Cancer Liquid Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
Table 38. Europe Breast Cancer Liquid Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Breast Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Breast Cancer Liquid Biopsy Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Breast Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Breast Cancer Liquid Biopsy
Table 47. Key Market Challenges & Risks of Breast Cancer Liquid Biopsy
Table 48. Key Industry Trends of Breast Cancer Liquid Biopsy
Table 49. Global Breast Cancer Liquid Biopsy Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Breast Cancer Liquid Biopsy Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Breast Cancer Liquid Biopsy Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Breast Cancer Liquid Biopsy Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. QIAGEN Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 54. QIAGEN Breast Cancer Liquid Biopsy Product Offered
Table 55. QIAGEN Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. QIAGEN Main Business
Table 57. QIAGEN Latest Developments
Table 58. Roche Diagnostics Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 59. Roche Diagnostics Breast Cancer Liquid Biopsy Product Offered
Table 60. Roche Diagnostics Main Business
Table 61. Roche Diagnostics Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Roche Diagnostics Latest Developments
Table 63. Bio-Rad Laboratories Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 64. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product Offered
Table 65. Bio-Rad Laboratories Main Business
Table 66. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Bio-Rad Laboratories Latest Developments
Table 68. Myriad Genetics Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 69. Myriad Genetics Breast Cancer Liquid Biopsy Product Offered
Table 70. Myriad Genetics Main Business
Table 71. Myriad Genetics Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Myriad Genetics Latest Developments
Table 73. Menarini Silicon Biosystems Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 74. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product Offered
Table 75. Menarini Silicon Biosystems Main Business
Table 76. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Menarini Silicon Biosystems Latest Developments
Table 78. Genomic Health Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 79. Genomic Health Breast Cancer Liquid Biopsy Product Offered
Table 80. Genomic Health Main Business
Table 81. Genomic Health Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Genomic Health Latest Developments
Table 83. Thermo Fisher Scientific Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 84. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product Offered
Table 85. Thermo Fisher Scientific Main Business
Table 86. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. Thermo Fisher Scientific Latest Developments
Table 88. Illumina Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 89. Illumina Breast Cancer Liquid Biopsy Product Offered
Table 90. Illumina Main Business
Table 91. Illumina Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Illumina Latest Developments
Table 93. Biocept Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 94. Biocept Breast Cancer Liquid Biopsy Product Offered
Table 95. Biocept Main Business
Table 96. Biocept Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Biocept Latest Developments
Table 98. Trovagene Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 99. Trovagene Breast Cancer Liquid Biopsy Product Offered
Table 100. Trovagene Main Business
Table 101. Trovagene Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Trovagene Latest Developments
Table 103. Guardant Health Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 104. Guardant Health Breast Cancer Liquid Biopsy Product Offered
Table 105. Guardant Health Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Guardant Health Main Business
Table 107. Guardant Health Latest Developments
Table 108. RainDance Technologies Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 109. RainDance Technologies Breast Cancer Liquid Biopsy Product Offered
Table 110. RainDance Technologies Main Business
Table 111. RainDance Technologies Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. RainDance Technologies Latest Developments
Table 113. MDx Health Details, Company Type, Breast Cancer Liquid Biopsy Area Served and Its Competitors
Table 114. MDx Health Breast Cancer Liquid Biopsy Product Offered
Table 115. MDx Health Main Business
Table 116. MDx Health Breast Cancer Liquid Biopsy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. MDx Health Latest Developments
LIST OF FIGURES
Figure 1. Breast Cancer Liquid Biopsy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Breast Cancer Liquid Biopsy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Breast Cancer Liquid Biopsy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Breast Cancer Liquid Biopsy Sales Market Share by Country/Region (2023)
Figure 8. Breast Cancer Liquid Biopsy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Breast Cancer Liquid Biopsy Market Size Market Share by Type in 2023
Figure 10. Breast Cancer Liquid Biopsy in Hospitals
Figure 11. Global Breast Cancer Liquid Biopsy Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Breast Cancer Liquid Biopsy in Diagnostic Centers
Figure 13. Global Breast Cancer Liquid Biopsy Market: Diagnostic Centers (2019-2024) & ($ Millions)
Figure 14. Breast Cancer Liquid Biopsy in Laboratories
Figure 15. Global Breast Cancer Liquid Biopsy Market: Laboratories (2019-2024) & ($ Millions)
Figure 16. Global Breast Cancer Liquid Biopsy Market Size Market Share by Application in 2023
Figure 17. Global Breast Cancer Liquid Biopsy Revenue Market Share by Player in 2023
Figure 18. Global Breast Cancer Liquid Biopsy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Breast Cancer Liquid Biopsy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Breast Cancer Liquid Biopsy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Breast Cancer Liquid Biopsy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Breast Cancer Liquid Biopsy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Breast Cancer Liquid Biopsy Value Market Share by Country in 2023
Figure 24. United States Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Breast Cancer Liquid Biopsy Market Size Market Share by Region in 2023
Figure 29. APAC Breast Cancer Liquid Biopsy Market Size Market Share by Type in 2023
Figure 30. APAC Breast Cancer Liquid Biopsy Market Size Market Share by Application in 2023
Figure 31. China Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Breast Cancer Liquid Biopsy Market Size Market Share by Country in 2023
Figure 38. Europe Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Breast Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Breast Cancer Liquid Biopsy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Breast Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 57. United States Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 61. China Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 65. India Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 68. France Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 69. UK Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 78. Global Breast Cancer Liquid Biopsy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Breast Cancer Liquid Biopsy Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Breast Cancer Liquid Biopsy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Breast Cancer Liquid Biopsy Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Breast Cancer Liquid Biopsy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Breast Cancer Liquid Biopsy Sales Market Share by Country/Region (2023)
Figure 8. Breast Cancer Liquid Biopsy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Breast Cancer Liquid Biopsy Market Size Market Share by Type in 2023
Figure 10. Breast Cancer Liquid Biopsy in Hospitals
Figure 11. Global Breast Cancer Liquid Biopsy Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. Breast Cancer Liquid Biopsy in Diagnostic Centers
Figure 13. Global Breast Cancer Liquid Biopsy Market: Diagnostic Centers (2019-2024) & ($ Millions)
Figure 14. Breast Cancer Liquid Biopsy in Laboratories
Figure 15. Global Breast Cancer Liquid Biopsy Market: Laboratories (2019-2024) & ($ Millions)
Figure 16. Global Breast Cancer Liquid Biopsy Market Size Market Share by Application in 2023
Figure 17. Global Breast Cancer Liquid Biopsy Revenue Market Share by Player in 2023
Figure 18. Global Breast Cancer Liquid Biopsy Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Breast Cancer Liquid Biopsy Market Size 2019-2024 ($ Millions)
Figure 20. APAC Breast Cancer Liquid Biopsy Market Size 2019-2024 ($ Millions)
Figure 21. Europe Breast Cancer Liquid Biopsy Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Breast Cancer Liquid Biopsy Market Size 2019-2024 ($ Millions)
Figure 23. Americas Breast Cancer Liquid Biopsy Value Market Share by Country in 2023
Figure 24. United States Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Breast Cancer Liquid Biopsy Market Size Market Share by Region in 2023
Figure 29. APAC Breast Cancer Liquid Biopsy Market Size Market Share by Type in 2023
Figure 30. APAC Breast Cancer Liquid Biopsy Market Size Market Share by Application in 2023
Figure 31. China Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Breast Cancer Liquid Biopsy Market Size Market Share by Country in 2023
Figure 38. Europe Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
Figure 39. Europe Breast Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
Figure 40. Germany Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Breast Cancer Liquid Biopsy Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Breast Cancer Liquid Biopsy Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Breast Cancer Liquid Biopsy Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Breast Cancer Liquid Biopsy Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 54. APAC Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 55. Europe Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 57. United States Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 58. Canada Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 61. China Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 62. Japan Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 63. Korea Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 65. India Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 66. Australia Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 67. Germany Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 68. France Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 69. UK Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 70. Italy Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 71. Russia Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 72. Spain Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 75. Israel Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Breast Cancer Liquid Biopsy Market Size 2025-2030 ($ Millions)
Figure 78. Global Breast Cancer Liquid Biopsy Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Breast Cancer Liquid Biopsy Market Size Market Share Forecast by Application (2025-2030)
